Thu04182024

Last updateTue, 16 Apr 2024 10am

Back You are here: Inicio Biology & biomedicine Technological offers

Obtaining three-dimensional cell cultures by ultrasound for in vitro studies

A team from ITEFI CSIC has developed an ultrasound system that allows the generation of cellular clusters in the form of spheres for in vitro studies. It enables the straightforward creation of stable three-dimensional cell cultures in just a few minutes.

Read more ...

A biomaterial based on eggshell membrane for bone regeneration

A multicentre study led by the CSIC has developed a biomaterial based on the eggshell membrane, which takes advantage of its natural qualities to obtain a biohybrid material with future applications in guided bone regeneration and pulp capping.

Read more ...

Removable basket for in vitro analysis of biological tissues

The CSIC and the Miguel Hernández University have developed a basket for in vitro tissue analysis. It enables to fix the sample and allowing its transport between wells without damaging it. It has an optimised design that allows the replacement of the mesh, the maximum use of the surface of the well and an efficient use of the reagents used.

Read more ...

A new risk predictor for breast cancer that improves on commercial tests used in clinical practice

The Laboratory of cancer bioinformatics and functional genomics from the Cancer Research Centre, a joint centre of the CSIC and the University of Salamanca (USAL), has designed a risk predictor for breast cancer patients using machine learning techniques. It allows the identification of genes associated with survival and risk of patients. The new test could be easily translated into the clinical practice, given that its development cost is similar to other routine techniques.

Read more ...

Antibodies against Alzheimer's disease

Scientists at the Centre for Molecular Biology (CBM), joint center of the CSIC and the UAM, have developed antibodies that neutralise the SFRP1 protein, which according to recent studies is a crucial player in the pathogenesis of Alzheimer's disease and a promising therapeutic target. The aim is to obtain a drug that can delay the progression of the disease. Now they are searching for partners to scale-up the trial for clinical use.

Read more ...